Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients

Abstract Background Therapy/prognosis of Non-Small Cell Lung Cancer (NSCLC) patients are strongly related to gene alteration/s or protein expression. However, more than 50% of NSCLC patients are negative to key drugable biomarkers. Methods We used human samples of NSCLC and mouse models of lung aden...

Full description

Bibliographic Details
Main Authors: Michela Terlizzi, Chiara Colarusso, Ilaria De Rosa, Pasquale Somma, Carlo Curcio, Rita P. Aquino, Luigi Panico, Rosario Salvi, Federica Zito Marino, Gerardo Botti, Aldo Pinto, Rosalinda Sorrentino
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-020-01754-0
_version_ 1818211873986707456
author Michela Terlizzi
Chiara Colarusso
Ilaria De Rosa
Pasquale Somma
Carlo Curcio
Rita P. Aquino
Luigi Panico
Rosario Salvi
Federica Zito Marino
Gerardo Botti
Aldo Pinto
Rosalinda Sorrentino
author_facet Michela Terlizzi
Chiara Colarusso
Ilaria De Rosa
Pasquale Somma
Carlo Curcio
Rita P. Aquino
Luigi Panico
Rosario Salvi
Federica Zito Marino
Gerardo Botti
Aldo Pinto
Rosalinda Sorrentino
author_sort Michela Terlizzi
collection DOAJ
description Abstract Background Therapy/prognosis of Non-Small Cell Lung Cancer (NSCLC) patients are strongly related to gene alteration/s or protein expression. However, more than 50% of NSCLC patients are negative to key drugable biomarkers. Methods We used human samples of NSCLC and mouse models of lung adenocarcinoma. Results We showed that caspase-4 was highly present in the tumor mass compared to non-cancerous human tissues. Interestingly, the orthologue murine caspase-11 promoted lung carcinogenesis in mice. Carcinogen-exposed caspase-11 knockout mice had lower tumor lesions than wild type mice, due to the relevance of caspase-11 in the structural lung cell as demonstrated by bone marrow transplantation and adoptive transfer experiments. Similarly to what observed in mice, caspase-4 was correlated to the stage of lung cancer in humans in that it induced cell proliferation in a K-Ras, c-MyC and IL-1α dependent manner. Caspase-4 positive adenocarcinoma (79.3%) and squamous carcinoma (88.2%) patients had lower median survival than patients who had lower levels of caspase-4. Moreover, PD-L1 expression and gene mutation (i.e. EGFR) were not correlated to caspase-4 expression. Instead, NSCLC patients who had K-Ras or c-MyC gene alteration were positively correlated to higher levels of caspase-4 and lower survival rate. Conclusions We identified a subgroup of NSCLC patients as caspase-4 positive among which double and triple positive caspase-4, K-Ras and/or c-MyC patients which prognosis was poor. Because K-Ras and c-MyC are still undrugable, the identification of caspase-4 as a novel oncoprotein could introduce novelty in the clinical yet unmet needs for NSCLC patients.
first_indexed 2024-12-12T05:39:25Z
format Article
id doaj.art-cb4538c17dda47399a2472c39472d744
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-12-12T05:39:25Z
publishDate 2020-11-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-cb4538c17dda47399a2472c39472d7442022-12-22T00:35:58ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662020-11-0139111710.1186/s13046-020-01754-0Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patientsMichela Terlizzi0Chiara Colarusso1Ilaria De Rosa2Pasquale Somma3Carlo Curcio4Rita P. Aquino5Luigi Panico6Rosario Salvi7Federica Zito Marino8Gerardo Botti9Aldo Pinto10Rosalinda Sorrentino11Department of Pharmacy (DIFARMA), University of SalernoDepartment of Pharmacy (DIFARMA), University of SalernoAnatomy and Pathology Unit, Ospedale dei Colli, AORN, “Monaldi”Anatomy and Pathology Unit, Ospedale dei Colli, AORN, “Monaldi”Thoracic Surgery Unit, Ospedale dei Colli, AORN, “Monaldi”Department of Pharmacy (DIFARMA), University of SalernoAnatomy and Pathology Unit, Ospedale dei Colli, AORN, “Monaldi”Thoracic Surgery Unit, Ospedale dei Colli, AORN, “Monaldi”Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania “Luigi Vanvitelli”Scientific Direction IRCCS National Cancer Institute “G. Pascale”Department of Pharmacy (DIFARMA), University of SalernoDepartment of Pharmacy (DIFARMA), University of SalernoAbstract Background Therapy/prognosis of Non-Small Cell Lung Cancer (NSCLC) patients are strongly related to gene alteration/s or protein expression. However, more than 50% of NSCLC patients are negative to key drugable biomarkers. Methods We used human samples of NSCLC and mouse models of lung adenocarcinoma. Results We showed that caspase-4 was highly present in the tumor mass compared to non-cancerous human tissues. Interestingly, the orthologue murine caspase-11 promoted lung carcinogenesis in mice. Carcinogen-exposed caspase-11 knockout mice had lower tumor lesions than wild type mice, due to the relevance of caspase-11 in the structural lung cell as demonstrated by bone marrow transplantation and adoptive transfer experiments. Similarly to what observed in mice, caspase-4 was correlated to the stage of lung cancer in humans in that it induced cell proliferation in a K-Ras, c-MyC and IL-1α dependent manner. Caspase-4 positive adenocarcinoma (79.3%) and squamous carcinoma (88.2%) patients had lower median survival than patients who had lower levels of caspase-4. Moreover, PD-L1 expression and gene mutation (i.e. EGFR) were not correlated to caspase-4 expression. Instead, NSCLC patients who had K-Ras or c-MyC gene alteration were positively correlated to higher levels of caspase-4 and lower survival rate. Conclusions We identified a subgroup of NSCLC patients as caspase-4 positive among which double and triple positive caspase-4, K-Ras and/or c-MyC patients which prognosis was poor. Because K-Ras and c-MyC are still undrugable, the identification of caspase-4 as a novel oncoprotein could introduce novelty in the clinical yet unmet needs for NSCLC patients.http://link.springer.com/article/10.1186/s13046-020-01754-0Lung cancerCaspase-4K-RascMycSurvival rateOncoprotein
spellingShingle Michela Terlizzi
Chiara Colarusso
Ilaria De Rosa
Pasquale Somma
Carlo Curcio
Rita P. Aquino
Luigi Panico
Rosario Salvi
Federica Zito Marino
Gerardo Botti
Aldo Pinto
Rosalinda Sorrentino
Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
Journal of Experimental & Clinical Cancer Research
Lung cancer
Caspase-4
K-Ras
cMyc
Survival rate
Oncoprotein
title Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
title_full Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
title_fullStr Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
title_full_unstemmed Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
title_short Identification of a novel subpopulation of Caspase-4 positive non-small cell lung Cancer patients
title_sort identification of a novel subpopulation of caspase 4 positive non small cell lung cancer patients
topic Lung cancer
Caspase-4
K-Ras
cMyc
Survival rate
Oncoprotein
url http://link.springer.com/article/10.1186/s13046-020-01754-0
work_keys_str_mv AT michelaterlizzi identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT chiaracolarusso identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT ilariaderosa identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT pasqualesomma identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT carlocurcio identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT ritapaquino identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT luigipanico identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT rosariosalvi identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT federicazitomarino identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT gerardobotti identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT aldopinto identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients
AT rosalindasorrentino identificationofanovelsubpopulationofcaspase4positivenonsmallcelllungcancerpatients